Trends and prospects in mitochondrial genome editing

참고문헌 (84)

1. Schell, J. C., "A role for the mitochondrial pyruvate carrier as a repressor of the Warburg effect and colon cancer cell growth", Mol. Cell, 56, pp.400~413 (2014)
2. Herzig, S., "Identification and functional expression of the mitochondrial pyruvate carrier", Science, 337, pp.93~96 (2012)
3. Filippi, M. -D., "Mitochondria in the maintenance of hematopoietic stem cells : new perspectives and opportunities", Blood, 133, pp.1943~1952 (2019)
4. Liu, X., "Induction of apoptotic program in cell-free extracts : requirement for dATP and cytochrome c", Cell, 86, pp.147~157 (1996)
5. Gomes, L. C., "During autophagy mitochondria elongate, are spared from degradation and sustain cell viability", Nat. Cell Biol, 13, pp.589~598 (2011)
6. Rambold Angelika, S., "Tubular network formation protects mitochondria from autophagosomal degradation during nutrient starvation", Proc. Natl Acad. Sci. USA, 108, pp.10190~10195 (2011)
7. i signalling in rat cerebellar granule neurones aged in vitro, "Neurobiol. Aging", 2004, 349~359
8. Tang, S., "Mitochondrial Ca²+ uniporter is critical for store-operated Ca2+entry-dependent breast cancer cell migration", Biochem. Biophys. Res. Commun, 458, pp.186~193 (2015)
9. Yasukawa, K., "Mitofusin 2 inhibits mitochondrial antiviral signaling", Sci. Signal, 2, pp.ra47~ (2009)
10. Kaniak-Golik, A., "Mitochondria–nucleus network for genome stability", Free Radic. Biol. Med, 82, pp.73~104 (2015)
11. Chen, X., "Rearranged mitochondrial genomes are present in human oocytes", Am. J. Hum. Genet, 57, pp.239~247 (1995)
12. D’Erchia, A. M., "Tissue-specific mtDNA abundance from exome data and its correlation with mitochondrial transcription, mass and respiratory activity", Mitochondrion, 20, pp.13~21 (2015)
13. Anderson, S., "Sequence and organization of the human mitochondrial genome", Nature, 290, pp.457~465 (1981)
14. Schon, K. R., "Mitochondrial diseases : a diagnostic revolution", Trends Genet, 36, pp.702~717 (2020)
15. Tuppen, H. A. L., "Mitochondrial DNA mutations and human disease", Biochim. Biophys. Acta Bioenerg, 1797, pp.113~128 (2010)
16. El-Hattab, A. W., "Mitochondrial cytopathies", Cell Calcium, 60, pp.199~206 (2016)
17. Leber, T., "Ueber hereditäre und congenital-angelegte Sehnervenleiden", Albrecht Graef. Arch. Ophthalmol, 17, pp.249~291 (1871)
18. Man, P. Y. W., "Leber hereditary optic neuropathy", J. Med. Genet, 39, pp.162~ (2002)
19. Shoffner, J. M., "Myoclonic epilepsy and ragged-red fiber disease(MERRF)is associated with a mitochondrial DNA tRNALys mutation", Cell, 61, pp.931~937 (1990)
20. Pfeffer, G., "Mutations in the SPG7 gene cause chronic progressive external ophthalmoplegia through disordered mitochondrial DNA maintenance", Brain, 137, pp.1323~1336 (2014)
21. Kauppila, J. H. K., "A phenotype-driven approach to generate mouse models with pathogenic mtDNA mutations causing mitochondrial disease", Cell Rep, 16, pp.2980~2990 (2016)
22. Srivastava, S., "Manipulating mitochondrial DNA heteroplasmy by a mitochondrially targeted restriction endonuclease", Hum. Mol. Genet, 10, pp.3093~3099 (2001)
23. Tanaka, M., "Gene therapy for mitochondrial disease by delivering restriction endonuclease SmaI into mitochondria", J. Biomed. Sci, 9, pp.534~541 (2002)
24. Bayona-Bafaluy Maria, P., "Rapid directional shift of mitochondrial DNA heteroplasmy in animal tissues by a mitochondrially targeted restriction endonuclease", Proc. Natl Acad. Sci. USA, 102, pp.14392~14397 (2005)
25. Wang, H., "CRISPR", Cas9 in genome editing and beyond, 2016, pp.85, 227~264
26. Jo, A., "Efficient mitochondrial genome editing by CRISPR", Cas9, 2015, pp.2015, 305716~305716
27. Bian, W. -P., "Knock-in strategy for editing human and zebrafish mitochondrial DNA using mito-CRISPR", Cas9 system, 2019, pp.8, 621~632
28. Gammage, P. A., "Mitochondrial genome engineering : the revolution may not be CRISPR-Ized", Trends Genet, 34, pp.101~110 (2018)
29. Hussain, S. A., "Adapting CRISPR", Cas9 system for targeting mitochondrial genome, 2021, pp.12, 627050~
30. Yin, T., "Current Progress of Mitochondrial Genome Editing by CRISPR", Front. Physiol (2022)[DOI]
31. Antón, Z., "Mitochondrial import, health and mtDNA copy number variability seen when using type II and type V CRISPR effectors", J. Cell Sci (2020)[DOI]
32. Kim, Y. G., "Hybrid restriction enzymes : zinc finger fusions to Fok I cleavage domain", Proc. Natl Acad. Sci. USA, 93, pp.1156~1160 (1996)
33. Smith, J., "Requirements for double-strand cleavage by chimeric restriction enzymes with zinc finger DNA-recognition domains", Nucleic Acids Res, 28, pp.3361~3369 (2000)
34. Christian, M., "Targeting DNA double-strand breaks with TAL effector nucleases", Genetics, 186, pp.757~761 (2010)
35. Gammage, P. A., "Mitochondrially targeted ZFNs for selective degradation of pathogenic mitochondrial genomes bearing large-scale deletions or point mutations", EMBO Mol. Med, 6, pp.458~466 (2014)
36. Bacman, S. R., "Specific elimination of mutant mitochondrial genomes in patient-derived cells by mitoTALENs", Nat. Med, 19, pp.1111~1113 (2013)
37. Beerli, R. R, "Toward controlling gene expression at will: specific regulation of the erbB-2", HER-2 promoter by using polydactyl zinc finger proteins constructed from modular building blocks, 1998, pp.95, 14628~14633
38. Beerli, R. R., "Positive and negative regulation of endogenous genes by designed transcription factors", Proc. Natl Acad. Sci. USA, 97, pp.1495~1500 (2000)
39. Gersbach, C. A., "Synthetic zinc finger proteins : the advent of targeted gene regulation and genome modification technologies", Acc. Chem. Res, 47, pp.2309~2318 (2014)
40. Minczuk, M., "Sequence-specific modification of mitochondrial DNA using a chimeric zinc finger methylase", Proc. Natl Acad. Sci. USA, 103, pp.19689~19694 (2006)
41. Minczuk, M., "Development of a single-chain, quasi-dimeric zinc-finger nuclease for the selective degradation of mutated human mitochondrial DNA", Nucleic Acids Res, 36, pp.3926~3938 (2008)
42. Minczuk, M., "Construction and testing of engineered zinc-finger proteins for sequence-specific modification of mtDNA", Nat. Protoc, 5, pp.342~356 (2010)
43. Gammage, P. A., "Near-complete elimination of mutant mtDNA by iterative or dynamic dose-controlled treatment with mtZFNs", Nucleic Acids Res, 44, pp.7804~7816 (2016)
44. Gaude, E., "NADH shuttling couples cytosolic reductive carboxylation of glutamine with glycolysis in cells with mitochondrial dysfunction", Mol. Cell, 69, pp.581~593 (2018)
45. Gammage, P. A., "Genome editing in mitochondria corrects a pathogenic mtDNA mutation in vivo", Nat. Med, 24, pp.1691~1695 (2018)
46. Lim, K., "Nuclear and mitochondrial DNA editing in human cells with zinc finger deaminases", Nat. Commun, 13, pp.366~ (2022)
47. Perez-Quintero, A. L., "A decade decoded : spies and hackers in the history of TAL effectors research", Annu. Rev. Phytopathol, 57, pp.459~481 (2019)
48. Boch, J., "Breaking the code of DNA binding specificity of TAL-type III effectors", Science, 326, pp.1509~1512 (2009)
49. Bogdanove, A. J., "TAL effectors: customizable proteins for DNA targeting", Science, 333, pp.1843~1846 (2011)
50. Richter, A., "TALENs: Methods and Protocols", pp.9~25 (2016), Springer
51. Gaj, T., "ZFN, TALEN, and CRISPR", Cas-based methods for genome engineering, 2013, pp.31, 397~405
52. Hashimoto, M., "MitoTALEN : a general approach to reduce mutant mtDNA loads and restore oxidative phosphorylation function in mitochondrial diseases", Mol. Ther, 23, pp.1592~1599 (2015)
53. Yahata, N., "TALEN-mediated shift of mitochondrial DNA heteroplasmy in MELAS-iPSCs with m.13513G>A mutation", Sci. Rep, 7, pp.15557~ (2017)
54. Yang, Y., "Targeted elimination of mutant mitochondrial DNA in MELAS-iPSCs by mitoTALENs", Protein Cell, 9, pp.283~297 (2018)
55. Phillips, A. F., "Single-molecule analysis of mtDNA replication uncovers the basis of the common deletion", Mol. Cell, 65, pp.527~538 (2017)
56. Tonin, Y., "Modeling of antigenomic therapy of mitochondrial diseases by mitochondrially addressed RNA targeting a pathogenic point mutation in mitochondrial DNA*", J. Biol. Chem, 289, pp.13323~13334 (2014)
57. Reddy, P., "Selective elimination of mitochondrial mutations in the germline by genome editing", Cell, 161, pp.459~469 (2015)
58. Pereira, C. V., "mitoTev-TALE : a monomeric DNA editing enzyme to reduce mutant mitochondrial DNA levels", EMBO Mol. Med, 10, pp.e8084~ (2018)
59. Mok, B. Y., "A bacterial cytidine deaminase toxin enables CRISPR-free mitochondrial base editing", Nature, 583, pp.631~637 (2020)
60. Wei, Y., "Human cleaving embryos enable efficient mitochondrial baseediting with DdCBE", Cell Discov, 8, pp.7~ (2022)
61. Sabharwal, A., "The FusX TALE base editor(FusXTBE)for rapid mitochondrial DNA programming of human cells in vitro and zebrafish disease models in vivo", CRISPR J, 4, pp.799~821 (2021)
62. Guo, J., "Precision modeling of mitochondrial diseases in zebrafish via DdCBEmediated mtDNA base editing", Cell Discov, 7, pp.78~ (2021)
63. Guo, J., "DdCBE mediates efficient and inheritable modifications in mouse mitochondrial genome", Mol. Ther, 27, pp.73~80 (2022)
64. Lee, H., "Mitochondrial DNA editing in mice with DddA-TALE fusion deaminases", Nat. Commun, 12, pp.1190~ (2021)
65. Qi, X., "Precision modeling of mitochondrial disease in rats via DdCBEmediated mtDNA editing", Cell Discov, 7, pp.95~ (2021)
66. Kang, B. -C., "Chloroplast and mitochondrial DNA editing in plants", Nat. Plants, 7, pp.899~905 (2021)
67. Silva-Pinheiro, P., "In vivo mitochondrial base editing via adeno-associated viral delivery to mouse post-mitotic tissue", Nat. Commun, 13, pp.750~ (2022)
68. Nakazato, I., "Targeted base editing in the plastid genome of Arabidopsis thaliana", Nat. Plants, 7, pp.906~913 (2021)
69. Cho, S. -I., "Targeted A-to-G base editing in human mitochondrial DNA with programmable deaminases", Cell, 185, pp.1764~1776 (2022)
70. Mok, B. Y., "CRISPR-free base editors with enhanced activity and expanded targeting scope in mitochondrial and nuclear DNA", Nat. Biotechnol (2022)[DOI]
71. Wei, Y., "Mitochondrial base editor DdCBE causes substantial DNA off-target editing in nuclear genome of embryos", Cell Discov, 8, pp.27~ (2022)
72. Lei, Z., "Mitochondrial base editor induces substantial nuclear off-target mutations", Nature (2022)[DOI]
73. Moraes, C. T., "A magic bullet to specifically eliminate mutated mitochondrial genomes from patients’ cells", EMBO Mol. Med, 6, pp.434~435 (2014)
74. Smirnov, A., "Biological significance of 5S rRNA import into human mitochondria : role of ribosomal protein MRP-L18", Genes Dev, 25, pp.1289~1305 (2011)
75. Puranam Ram, S., "The RNase P associated with HeLa cell mitochondria contains an essential RNA component identical in sequence to that of the nuclear RNase P", Mol. Cell. Biol, 21, pp.548~561 (2001)
76. Mercer, TimR., "The human mitochondrial transcriptome", Cell, 146, pp.645~658 (2011)
77. Zelenka, J., "Mitochondrial DNA: Methods and Protocols", pp.175~181 (2016), Springer
78. Towheed, A., "Small mitochondrial-targeted RNAs modulate endogenous mitochondrial protein expression in vivo", Neurobiol. Dis, 69, pp.15~22 (2014)
79. Smirnov, A., "Two distinct structural elements of 5S rRNA are needed for its import into human mitochondria", RNA, 14, pp.749~759 (2008)
80. Yu, H., "Gene delivery to mitochondria by targeting modified adenoassociated virus suppresses Leber’s hereditary optic neuropathy in a mouse model", Proc. Natl Acad. Sci. USA, 109, pp.E1238~E1247 (2012)
81. Banskota, S., "Engineered virus-like particles for efficient in vivo delivery of therapeutic proteins", Cell, 185, pp.250~265 (2022)
82. Mangeot, P. E., "Genome editing in primary cells and in vivo using viralderived Nanoblades loaded with Cas9-sgRNA ribonucleoproteins", Nat. Commun, 10, pp.45~ (2019)
83. Wu, Z., "Programmed genome editing by a miniature CRISPR-Cas12f nuclease", Nat. Chem. Biol, 17, pp.1132~1138 (2021)
84. Wang, Y., "Guide RNA engineering enables efficient CRISPR editing with a miniature Syntrophomonas palmitatica Cas12f1 nuclease", Cell Rep, 40, pp.111418~ (2022)

관련 논문AI추천